• Profile
Close

Neuropsychiatric symptoms and α-Synuclein profile of patients with Parkinson’s disease dementia, dementia with Lewy bodies and Alzheimer’s disease

Journal of Neurology Aug 10, 2018

Bougea A, et al. - In this prospective cross-sectional study, researchers compared the neuropsychiatric and cerebrospinal fluid (CSF) α-Synuclein (α-Syn) profiles in conditions like Parkinson’s disease dementia (PDD), dementia with Lewy bodies (DLB) and Alzheimer’s disease (AD), and examined the possible relationship between CSF α-Syn levels and neuropsychiatric symptoms. Participants in the study were 16 PDD, 28 DLB and 19 AD patients between January 2013 and January 2015. No association was found between Neuropsychiatric Inventory (NPI) scores and α-Syn levels. Still, increased NPI scores and α-Syn levels are linked to greater likelihood for being in DLB than in PDD or AD groups. The findings from the present study suggested that NPI scores and CSF α-Syn levels were valuable as independent variables to differentiate DLB from PDD and AD.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay